Molecular Detection Mycobacteria
Within scope of accreditation
WHO estimates that over 4 000 people die every day from tuberculosis. It is essential that laboratories are able to isolate and identify Mycobacterium tuberculosis and other rarer species that cause disease. Rapid diagnosis has been made possible with the development of molecular methods which includes the ability to test for resistance to anti-tuberculous drugs
PURPOSE OF PROGRAMME:
To provide EQA for laboratories determining the presence of mycobacteria with molecular assays.
PROGRAMME OF ANALYSIS:
Results are entered online via the UK NEQAS secure website. The distribution is open for eight weeks. Intended results are usually uploaded the day after closing date. Late results are not accepted after intended results are uploaded.
Qualitative detection/ identification, rifampicin resistance, concordance with the intended result. General descriptive statistics.
PERSISTENT POOR PERFORMANCE:
See the Annual Directory for UK and Irish participants only
The first distribution of UK NEQAS for Microbiology was sent out by the then Public Health Laboratory Services on the 1st of May 1971 organised by Dr Peter Crone. This distribution consisted of one scheme, three bacteriology specimens, sent to 67 laboratories in the UK. One of our recent distributions consisted of 12 different schemes, comprising 8 bacteriology, 13 serology, 10 molecular and 9 mycology specimens, and sent to 53 countries representing over 1300 laboratories. UK NEQAS for Microbiology, operated by Public Health England, is a UKAS accredited proficiency testing provider No. 4715.